Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Arbele Limited
Arbele Limited
National Cancer Institute (NCI)
Seoul National University Hospital
University Hospital, Bordeaux
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Taiho Oncology, Inc.
University Hospital, Angers
Hoosier Cancer Research Network
West China Hospital
Hoffmann-La Roche
Imugene Limited
M.D. Anderson Cancer Center
AstraZeneca
Yale University
Eisai Inc.
Elevar Therapeutics
Tianjin Medical University Cancer Institute and Hospital
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Seagen Inc.
National Institutes of Health Clinical Center (CC)
University of California, Irvine
University of Kansas Medical Center
Jazz Pharmaceuticals
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
National Cancer Institute (NCI)
Servier
Arvinas Inc.
Case Comprehensive Cancer Center
Myeloid Therapeutics
Stanford University
Jonsson Comprehensive Cancer Center
University of Kentucky
Oslo University Hospital
DualityBio Inc.
Peking University
Bold Therapeutics, Inc.
Big Ten Cancer Research Consortium
J-Pharma Co., Ltd.
SOFIE
Genfit
Sun Yat-sen University
Massachusetts General Hospital
Aichi Medical University
Seagen Inc.
TransThera Sciences (Nanjing), Inc.
Apollo Therapeutics Ltd